Evidence map›Paper›PMID 33558762›Full record

ArticleNature structural & molecular biology2021

Structural insights into the assembly and substrate selectivity of human SPT-ORMDL3 complex.

Sisi Li, Tian Xie, Peng Liu, Lei Wang, Xin Gong

Abstract read
PubMed Publisher
In one paragraph

Article in Nature structural & molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
6.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Deletion of exon 2 in ALS-linkedLife science alliance · 2026
    Article
  3. Sphingolipids and Atherosclerosis.Current atherosclerosis reports · 2026
    Review
  4. Characterization of novel and recurrentJournal of neuromuscular diseases · 2026
    Article
  5. Article
  6. Review
  7. ORMDL Proteins Turnover via Proteasome and Autophagy Is Cell-Type Dependent and Tied to Ceramide Homeostasis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sisi Li *Department of Biology, Southern University of Science and Technology, Shenzhen, Guangdong, China.ORCID http://orcid.org/0000-0002-7290-8128
Tian Xie *Department of Biology, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Peng Liu *Department of Biology, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Lei WangDepartment of Biology, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Xin GongDepartment of Biology, Southern University of Science and Technology, Shenzhen, Guangdong, China. gongx@sustech.edu.cn.ORCID http://orcid.org/0000-0003-3469-7718
Southern University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human serine palmitoyltransferase (SPT) complex catalyzes the initial and rate-limiting step in the de novo biosynthesis of all sphingolipids. ORMDLs regulate SPT function, with human ORMDL3 being related to asthma. Here we report three high-resolution cryo-EM structures: the human SPT complex, composed of SPTLC1, SPTLC2 and SPTssa; the SPT-ORMDL3 complex; and the SPT-ORMDL3 complex bound to two substrates, PLP-L-serine (PLS) and a non-reactive palmitoyl-CoA analogue. SPTLC1 and SPTLC2 form a dimer of heterodimers as the catalytic core. SPTssa participates in acyl-CoA coordination, thereby stimulating the SPT activity and regulating the substrate selectivity. ORMDL3 is located in the center of the complex, serving to stabilize the SPT assembly. Our structural and biochemical analyses provide a molecular basis for the assembly and substrate selectivity of the SPT and SPT-ORMDL3 complexes, and lay a foundation for mechanistic understanding of sphingolipid homeostasis and for related therapeutic drug development.

Indexed as

Cryoelectron MicroscopyMultiprotein ComplexesAcyl Coenzyme ABinding SitesBiocatalysisHumansMembrane ProteinsModels, MolecularMutationPyridoxal PhosphateReproducibility of ResultsSerineSerine C-PalmitoyltransferaseSubstrate SpecificityAcyl Coenzyme AMembrane ProteinsMultiprotein ComplexesORMDL3 protein, humanPyridoxal PhosphateSerineSerine C-PalmitoyltransferaseSPTLC1 protein, humanSPTLC2 protein, humanssSPTa

Identifiers

PMID33558762
OpenAlexW3127488501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.